References:
1. Takai Y, Misu T, Kaneko K, Chihara N, Narikawa K, Tsuchida S, et al.
(2020) Myelin oligodendrocyte glycoprotein antibody-associated disease:
an immunopathological study. Brain: a journal of neurology
143(5):1431-46. doi:10.1093/brain/awaa102
2. Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, et al.
(2018) MOG encephalomyelitis: international recommendations on diagnosis
and antibody testing. Journal of neuroinflammation 15(1):134. doi:
10.1186/s12974-018-1144-2
3. Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et
al. (2023) Diagnosis of myelin oligodendrocyte glycoprotein
antibody-associated disease: International MOGAD Panel proposed
criteria. The Lancet Neurology 22(3):268-82.
doi:10.1016/S1474-4422(22)00431-8
4. Yao T, Zeng Q, Xie Y, Bi F, Zhang L, Xiao B, et al. (2022) Clinical
analysis of adult MOG antibody-associated cortical encephalitis. Mult
Scler Relat Disord 60:103727. doi: 10.1016/ j. msard.2022.103727
5. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR,
Balice-Gordon R. (2011) Clinical experience and laboratory
investigations in patients with anti-NMDAR encephalitis. The Lancet
Neurology 10(1):63-74. doi:10.1016/S1474-4422(10)70253-2
6. Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al.
(2016) A clinical approach to diagnosis of autoimmune encephalitis. The
Lancet Neurology 15(4):391-404. doi:10.1016/S1474-4422(15)00401-9
7. Martinez-Hernandez E, Guasp M, Garcia-Serra A, Maudes E, Arino H,
Sepulveda M, et al. (2020) Clinical significance of anti-NMDAR
concurrent with glial or neuronal surface antibodies. Neurology 94(22):
e2302-e10. doi:10.1212/WNL. 0000000000009239
8. Titulaer MJ, Hoftberger R, Iizuka T, Leypoldt F, McCracken L,
Cellucci T, et al. (2014) Overlapping demyelinating syndromes and
anti-N-methyl-D-aspartate receptor encephalitis. Annals of neurology
75(3):411-28. doi:10.1002/ana.24117
9. Ogawa R, Nakashima I, Takahashi T, Kaneko K, Akaishi T, Takai Y, et
al. (2017) MOG antibody-positive, benign, unilateral, cerebral cortical
encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflamm 4(2): e322.
doi:10.1212/NXI. 0000000000000322
10. Budhram A, Mirian A, Le C, Hosseini-Moghaddam SM, Sharma M, Nicolle
MW. (2019) Unilateral cortical FLAIR-hyperintense Lesions in
Anti-MOG-associated Encephalitis with Seizures (FLAMES):
characterization of a distinct clinico-radiographic syndrome. J Neurol
266(10):2481-7. doi:10.1007/s00415-019-09440-8
11. Fan S, Xu Y, Ren H, Guan H, Feng F, Gao X, et al. (2018) Comparison
of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and
AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when
they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor
encephalitis. Mult Scler Relat Disord 20:144-52. doi:10.1016/ j.
msard.2018.01.007
12. Nan D, Zhang Y, Han J, Jin T. (2021) Clinical features and
management of coexisting anti-N-methyl-D-aspartate receptor encephalitis
and myelin oligodendrocyte glycoprotein antibody-associated
encephalomyelitis: a case report and review of the literature. Neurol
Sci 42(3):847-55. doi:10.1007/ s10072-020-04942-0
13. Perez CA, Agyei P, Gogia B, Harrison R, Samudralwar R. (2020)
Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR
encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody
disease. Journal of neuroimmunology 339: 577124. doi:
10.1016/j.jneuroim.2019.577124
14. Berek K, Grams A, Uprimny C, Prieschl M, Ramberger M, Unterberger I,
et al. (2022) Anti-NMDA receptor encephalitis and MOG-associated
demyelination - a case report with long-term follow-up and a systematic
review. BMC Neurol 22(1):434. doi:10.1186/s12883-022-02974-x
15. Yang JX, Yang MM, Han YJ, Gao CH, Cao J. (2023) FLAIR-hyperintense
lesions in anti-MOG-associated encephalitis with seizures overlaying
anti-N-methyl-D-aspartate receptor encephalitis: a case report and
literature review. Frontiers in immunology. 14:1149987
doi:10.3389/fimmu.2023.1149987
16. Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, et
al. (2011) Complement activating antibodies to myelin oligodendrocyte
glycoprotein in neuromyelitis optica and related disorders. Journal of
neuroinflammation 8:184. doi:10.1186/1742-2094-8-184
17. Ren BY, Guo Y, Han J, Wang Q, Li ZW. (2021) Case Report: Anti-NMDAR
Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS
Demyelination. Front Neurol 12:639265. doi:10.3389/fneur.2021. 639265
18. Valencia-Sanchez, C, Guo Y, Krecke KN, Chen JJ, Redenbaugh V,
Montalvo M, Elsbernd PM, Tillema JM, Lopez-Chiriboga S, Budhram A, Sechi
E, Kunchok A, Dubey D, Pittock SJ, Lucchinetti CF, and Flanagan EP.
(2023) Cerebral Cortical Encephalitis in Myelin Oligodendrocyte
Glycoprotein Antibody-Associated Disease. Annals of neurology 93,
297-302. doi:10.1002/ana.26549
19. Kunchok A, Flanagan EP, Krecke KN, Chen JJ, Caceres JA, Dominick J,
et al. (2021) MOG-IgG1 and co-existence of neuronal autoantibodies. Mult
Scler 27(8):1175-86. doi:10.1177/1352458520951046
20. Cherian A, Divya KP, Shetty SC, Kannoth S, Thomas B. (2020)
Coexistent MOG, NMDAR, CASPR2 antibody positivity: Triumph over the
triumvirate. Mult Scler Relat Disord 46:102468. doi:
10.1016/j.msard.2020.102468
21. Pruss H. (2017) Postviral autoimmune encephalitis: manifestations in
children and adults. Curr Opin Neurol 30(3):327-33. doi:10.1097/WCO.
0000000000000445
22. Mariotto S, Ferrari S, Monaco S, Benedetti MD, Schanda K, Alberti D,
et al. (2017) Clinical spectrum and IgG subclass analysis of anti-myelin
oligodendrocyte glycoprotein antibody-associated syndromes: a
multicenter study. J Neurol 264(12):2420-30.
doi.:10.1007/s00415-017-8635-4
23. Brunner C, Lassmann H, Waehneldt TV, Matthieu JM, Linington C.
(1989) Differential ultrastructural localization of myelin basic
protein, myelin/oligodendroglial glycoprotein, and 2’,3’-cyclic
nucleotide 3’-phosphodiesterase in the CNS of adult rats. J Neurochem
52(1):296-304. doi:10.1111/j.1471-4159. 1989.tb10930.x
24. Mayer MC, Meinl E. (2012) Glycoproteins as targets of autoantibodies
in CNS inflammation: MOG and more. Therapeutic advances in neurological
disorders 5(3):147-59. doi:10.1177/1756285611433772
25. Lipton SA. (2006) NMDA receptors, glial cells, and clinical
medicine. Neuron 50(1):9-11. doi: 10.1016/j.neuron.2006.03.026
26. McLeod DS, Woods ML, Kandiah DA. (2011) Immune reconstitution
inflammatory syndrome manifesting as development of multiple autoimmune
disorders and skin cancer progression. Intern Med J 41(9):699-703. doi:
10.1111/j.1445-5994.2011. 02546.x
27. Clifford DB. (2015) Neurological immune reconstitution inflammatory
response: riding the tide of immune recovery. Curr Opin Neurol
28(3):295-301. doi: 10.1097/WCO.0000000000000200
28. Van Obberghen EK, Cohen M, Rocher F, Lebrun-Frenay C. (2017)
Multiple immune disorders after natalizumab discontinuation: After the
CIRIS, the SIRIS? Rev Neurol (Paris) 173(4):222-4. doi:
10.1016/j.neurol.2017.03.008
29. Vega E, Arrambide G, Olive G, Castillo M, Felipe-Rucian A, Tintore
M, et al. (2023) non-ADEM encephalitis in patients with myelin
oligodendrocyte glycoprotein antibodies: a systematic review. Eur J
Neurol 30(5):1515-27. doi:10.1111/ene.15684
30. Zhou L, ZhangBao J, Li H, Li X, Huang Y, Wang M, et al. (2017)
Cerebral cortical encephalitis followed by recurrent CNS demyelination
in a patient with concomitant anti-MOG and anti-NMDA receptor
antibodies. Mult Scler Relat Disord 18:90-2. doi: 10.1016/j.msard.
2017.09.023
31. Zhou J, Tan W, Tan SE, Hu J, Chen Z, Wang K. (2018) An unusual case
of anti-MOG CNS demyelination with concomitant mild anti-NMDAR
encephalitis. Journal of neuroimmunology 320:107-10. doi:
10.1016/j.jneuroim.2018.03.019